Colorectal Cancer Screening

Restricted access

Mortality from colorectal cancer can be reduced by early diagnosis and by cancer prevention through polypectomy. These NCCN Guidelines for Colorectal Cancer Screening describe various colorectal screening modalities and recommended screening schedules for patients at average or increased risk of developing colorectal cancer. In addition, the guidelines provide recommendations for the management of patients with high-risk colorectal cancer syndromes, including Lynch syndrome. Screening approaches for Lynch syndrome are also described.

  • 1.

    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:1130.

  • 2.

    Cheng L, Eng C, Nieman LZ. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011;34:573580.

    • Search Google Scholar
    • Export Citation
  • 3.

    Eheman C, Henley SJ, Ballard-Barbash R. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:23382366.

    • Search Google Scholar
    • Export Citation
  • 4.

    Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212236.

    • Search Google Scholar
    • Export Citation
  • 5.

    Gunderson LL, Jessup JM, Sargent DJ. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010;28:264271.

    • Search Google Scholar
    • Export Citation
  • 6.

    Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005;128:16961716.

  • 7.

    Giardiello FM, Offerhaus JG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer 1995;31A:10851087.

  • 8.

    Hamilton SR, Liu B, Parsons RE. The molecular basis of Turcot’s syndrome. N Engl J Med 1995;332:839847.

  • 9.

    Levin B, Lieberman DA, McFarland B. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130160.

    • Search Google Scholar
    • Export Citation
  • 10.

    Rex DK, Johnson DA, Anderson JC. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739750.

    • Search Google Scholar
    • Export Citation
  • 11.

    U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627637.

    • Search Google Scholar
    • Export Citation
  • 12.

    Centers for Disease Control and Prevention (CDC). Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:4145.

  • 13.

    Burt RW. Colorectal cancer screening. Curr Opin Gastroenterol 2010;26:466470.

  • 14.

    Warren JL, Klabunde CN, Mariotto AB. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009;150:849857, W152.

    • Search Google Scholar
    • Export Citation
  • 15.

    Citarda F, Tomaselli G, Capocaccia R. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812815.

    • Search Google Scholar
    • Export Citation
  • 16.

    Jacob BJ, Moineddin R, Sutradhar R. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc 2012;76:355364 e351.

    • Search Google Scholar
    • Export Citation
  • 17.

    Winawer SJ, Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:19771981.

    • Search Google Scholar
    • Export Citation
  • 18.

    Manser CN, Bachmann LM, Brunner J. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012;76:110117.

    • Search Google Scholar
    • Export Citation
  • 19.

    Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904910.

    • Search Google Scholar
    • Export Citation
  • 20.

    Rabeneck L, Paszat LF, Saskin R, Stukel TA. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 2010;105:16271632.

    • Search Google Scholar
    • Export Citation
  • 21.

    Baxter NN, Goldwasser MA, Paszat LF. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:18.

  • 22.

    Barclay RL, Vicari JJ, Doughty AS. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:25332541.

    • Search Google Scholar
    • Export Citation
  • 23.

    Radaelli F, Meucci G, Sgroi G, Minoli G. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008;103:11221130.

    • Search Google Scholar
    • Export Citation
  • 24.

    Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770775; quiz 711.

    • Search Google Scholar
    • Export Citation
  • 25.

    Zauber AG, Winawer SJ, O’Brien MJ. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687696.

    • Search Google Scholar
    • Export Citation
  • 26.

    Brenner H, Chang-Claude J, Seiler CM. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:2230.

    • Search Google Scholar
    • Export Citation
  • 27.

    Baxter NN, Warren JL, Barrett MJ. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012;30:26642669.

    • Search Google Scholar
    • Export Citation
  • 28.

    Quintero E, Castells A, Bujanda L. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697706.

    • Search Google Scholar
    • Export Citation
  • 29.

    Hassan C, Giorgi Rossi P, Camilloni L. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 2012;36:929940.

    • Search Google Scholar
    • Export Citation
  • 30.

    Kaminski MF, Regula J, Kraszewska E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:17951803.

  • 31.

    Lieberman D, Nadel M, Smith RA. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007;65:757766.

    • Search Google Scholar
    • Export Citation
  • 32.

    Rex DK, Cummings OW, Helper DJ. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology 1996;111:11781181.

    • Search Google Scholar
    • Export Citation
  • 33.

    Imperiale TF, Glowinski EA, Lin-Cooper C. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:12181224.

    • Search Google Scholar
    • Export Citation
  • 34.

    Lieberman DA, Weiss DG, Harford WV. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:10771085.

  • 35.

    Singh H, Turner D, Xue L. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:23662373.

    • Search Google Scholar
    • Export Citation
  • 36.

    Brenner H, Chang-Claude J, Seiler CM. Does a negative screening colonoscopy ever need to be repeated? Gut 2006;55:11451150.

  • 37.

    Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 2011;29:37613767.

    • Search Google Scholar
    • Export Citation
  • 38.

    Newcomb PA, Norfleet RG, Storer BE. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:15721575.

  • 39.

    Atkin WS, Edwards R, Kralj-Hans I. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:16241633.

    • Search Google Scholar
    • Export Citation
  • 40.

    Segnan N, Armaroli P, Bonelli L. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst 2011;103:13101322.

    • Search Google Scholar
    • Export Citation
  • 41.

    Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.

    • Search Google Scholar
    • Export Citation
  • 42.

    Schoen RE, Pinsky PF, Weissfeld JL. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:23452357.

    • Search Google Scholar
    • Export Citation
  • 43.

    Weissfeld JL, Schoen RE, Pinsky PF. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989997.

    • Search Google Scholar
    • Export Citation
  • 44.

    Weissfeld JL, Schoen RE, Pinsky PF. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst 2012;104:280289.

    • Search Google Scholar
    • Export Citation
  • 45.

    Elmunzer BJ, Hayward RA, Schoenfeld PS. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012;9:e1001352.

    • Search Google Scholar
    • Export Citation
  • 46.

    Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. Mayo Clin Proc 2013;88:464470.

    • Search Google Scholar
    • Export Citation
  • 47.

    Doubeni CA, Weinmann S, Adams K. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 2013;158:312320.

    • Search Google Scholar
    • Export Citation
  • 48.

    Schoen RE, Pinsky PF, Weissfeld JL. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc 2012;75:612620.

    • Search Google Scholar
    • Export Citation
  • 49.

    Kim DH, Pickhardt PJ, Taylor AJ, Menias CO. Imaging evaluation of complications at optical colonoscopy. Curr Probl Diagn Radiol 2008;37:165177.

    • Search Google Scholar
    • Export Citation
  • 50.

    Whitlock EP, Lin JS, Liles E. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638658.

    • Search Google Scholar
    • Export Citation
  • 51.

    Johnson CD, Chen MH, Toledano AY. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:12071217.

  • 52.

    Johnson CD, Toledano AY, Herman BA. Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology 2003;125:688695.

    • Search Google Scholar
    • Export Citation
  • 53.

    Rockey DC, Paulson E, Niedzwiecki D. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005;365:305311.

    • Search Google Scholar
    • Export Citation
  • 54.

    Pickhardt PJ, Choi JR, Hwang I. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:21912200.

    • Search Google Scholar
    • Export Citation
  • 55.

    Kim DH, Pickhardt PJ, Taylor AJ. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007;357:14031412.

    • Search Google Scholar
    • Export Citation
  • 56.

    Halligan S, Altman DG, Taylor SA. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237:893904.

    • Search Google Scholar
    • Export Citation
  • 57.

    Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005;142:635650.

  • 58.

    Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection—systematic review and meta-analysis. Radiology 2011;259:393405.

    • Search Google Scholar
    • Export Citation
  • 59.

    de Haan MC, van Gelder RE, Graser A. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol 2011;21:17471763.

    • Search Google Scholar
    • Export Citation
  • 60.

    Stoop EM, de Haan MC, de Wijkerslooth TR. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012;13:5564.

    • Search Google Scholar
    • Export Citation
  • 61.

    Zalis ME, Blake MA, Cai W. Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med 2012;156:692702.

    • Search Google Scholar
    • Export Citation
  • 62.

    Fletcher JG, Chen MH, Herman BA. Can radiologist training and testing ensure high performance in CT colonography? Lessons from the National CT Colonography Trial. AJR Am J Roentgenol 2010;195:117125.

    • Search Google Scholar
    • Export Citation
  • 63.

    Lin OS. Computed tomographic colonography: hope or hype? World J Gastroenterol 2010;16:915920.

  • 64.

    Berrington de Gonzalez A, Kim KP, Yee J. CT colonography: perforation rates and potential radiation risks. Gastrointest Endosc Clin N Am 2010;20:279291.

    • Search Google Scholar
    • Export Citation
  • 65.

    ACR Practice Guideline for the Performance of Coputed Tomography (CT) Colonography in Adults. 2009. Available at: http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/CT_Colonography.pdf. Accessed June 1, 2011.

    • Search Google Scholar
    • Export Citation
  • 66.

    Sox HC. Office-based testing for fecal occult blood: do only in case of emergency. Ann Intern Med 2005;142:146148.

  • 67.

    Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:8185.

    • Search Google Scholar
    • Export Citation
  • 68.

    Nadel MR, Berkowitz Z, Klabunde CN. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med 2010;25:833839.

    • Search Google Scholar
    • Export Citation
  • 69.

    Hardcastle JD, Chamberlain JO, Robinson MH. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:14721477.

    • Search Google Scholar
    • Export Citation
  • 70.

    Kronborg O, Fenger C, Olsen J. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:14671471.

  • 71.

    Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:13651371.

    • Search Google Scholar
    • Export Citation
  • 72.

    Scholefield JH, Moss SM, Mangham CM. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012;61:10361040.

    • Search Google Scholar
    • Export Citation
  • 73.

    Hewitson P, Glasziou P, Watson E. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:15411549.

    • Search Google Scholar
    • Export Citation
  • 74.

    Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155159.

    • Search Google Scholar
    • Export Citation
  • 75.

    Lee TJ, Clifford GM, Rajasekhar P. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme. J Med Screen 2011;18:8286.

    • Search Google Scholar
    • Export Citation
  • 76.

    Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162169.

    • Search Google Scholar
    • Export Citation
  • 77.

    Allison JE, Sakoda LC, Levin TR. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:14621470.

    • Search Google Scholar
    • Export Citation
  • 78.

    Hol L, Van Leerdam ME, Van Ballegooijen M. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:6268.

    • Search Google Scholar
    • Export Citation
  • 79.

    Imperiale TF. Noninvasive screening tests for colorectal cancer. Dig Dis 2012;30(Suppl 2):1626.

  • 80.

    Park DI, Ryu S, Kim YH. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:20172025.

    • Search Google Scholar
    • Export Citation
  • 81.

    Parra-Blanco A, Gimeno-Garcia AZ, Quintero E. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010;45:703712.

    • Search Google Scholar
    • Export Citation
  • 82.

    Rabeneck L, Rumble RB, Thompson F. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012;26:131147.

    • Search Google Scholar
    • Export Citation
  • 83.

    Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192206.

  • 84.

    Imperiale TF, Ransohoff DF, Itzkowitz SH. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:27042714.

    • Search Google Scholar
    • Export Citation
  • 85.

    Ahlquist DA, Sargent DJ, Loprinzi CL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441450, W481.

    • Search Google Scholar
    • Export Citation
  • 86.

    Ahlquist DA, Zou H, Domanico M. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142:248256; quiz e225-246.

    • Search Google Scholar
    • Export Citation
  • 87.

    Ned RM, Melillo S, Marrone M. Fecal DNA testing for colorectal cancer screening: the ColoSure test. PLoS Curr 2011;3:RRN1220.

  • 88.

    Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed 2005;7:60.

  • 89.

    Kadouri L, Hubert A, Rotenberg Y. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet 2007;44:467471.

  • 90.

    Luo W, Cao Y, Liao C, Gao F. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies. Colorectal Dis 2012;14:13011312.

    • Search Google Scholar
    • Export Citation
  • 91.

    Theuer CP, Wagner JL, Taylor TH. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology 2001;120:848856.

    • Search Google Scholar
    • Export Citation
  • 92.

    Agrawal S, Bhupinderjit A, Bhutani MS. Colorectal cancer in African Americans. Am J Gastroenterol 2005;100:515523; discussion 514.

  • 93.

    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:1029.

  • 94.

    Knudsen AB, Hur C, Gazelle GS. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med 2012;157:611620.

    • Search Google Scholar
    • Export Citation
  • 95.

    Heresbach D, Barrioz T, Lapalus MG. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008;40:284290.

    • Search Google Scholar
    • Export Citation
  • 96.

    Alvarez C, Andreu M, Castells A. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc 2013;78:333341.

    • Search Google Scholar
    • Export Citation
  • 97.

    Rex DK, Ahnen DJ, Baron JA. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:13151329; quiz 1314, 1330.

    • Search Google Scholar
    • Export Citation
  • 98.

    Salaria SN, Streppel MM, Lee LA. Sessile serrated adenomas: high-risk lesions? Hum Pathol 2012;43:18081814.

  • 99.

    Chow E, Lipton L, Lynch E. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:3039.

    • Search Google Scholar
    • Export Citation
  • 100.

    Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006;38:266270.

  • 101.

    Yeoman A, Young J, Arnold J. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J 2007;120:U2827.

    • Search Google Scholar
    • Export Citation
  • 102.

    Ferrandez A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004;99:20122018.

    • Search Google Scholar
    • Export Citation
  • 103.

    Leggett BA, Devereaux B, Biden K. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177184.

  • 104.

    Winawer SJ, Zauber AG, Fletcher RH. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143159; quiz 184-145.

    • Search Google Scholar
    • Export Citation
  • 105.

    Lieberman DA, Rex DK, Winawer SJ. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844857.

    • Search Google Scholar
    • Export Citation
  • 106.

    Robertson DJ, Burke CA, Welch HG. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009;151:103109.

    • Search Google Scholar
    • Export Citation
  • 107.

    O’Brien MJ, Winawer SJ, Zauber AG. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371379.

    • Search Google Scholar
    • Export Citation
  • 108.

    Golembeski C, McKenna B, Appelman HD. Advanced adenomas: pathologists don’t agree [abstract]. Modern Pathology 2007;20:Abstract 115A.

  • 109.

    Brenner H, Chang-Claude J, Rickert A. Risk of colorectal cancer after detection and removal of adenomas at colonoscopy: population-based case-control study. J Clin Oncol 2012;30:29692976.

    • Search Google Scholar
    • Export Citation
  • 110.

    Walsh RM, Ackroyd FW, Shellito PC. Endoscopic resection of large sessile colorectal polyps. Gastrointest Endosc 1992;38:303309.

  • 111.

    Rex DK, Kahi CJ, Levin B. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006;56:160167; quiz 185-166.

    • Search Google Scholar
    • Export Citation
  • 112.

    Rodriguez-Moranta F, Salo J, Arcusa A. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386393.

    • Search Google Scholar
    • Export Citation
  • 113.

    Sargent DJ, Wieand HS, Haller DG. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005;23:86648670.

    • Search Google Scholar
    • Export Citation
  • 114.

    Shureiqi I, Cooksley CD, Morris J. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst 2001;93:12641266.

  • 115.

    Hoffman JP, Riley L, Carp NZ, Litwin S. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 1993;20:506519.

    • Search Google Scholar
    • Export Citation
  • 116.

    Lowy AM, Rich TA, Skibber JM. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma. Ann Surg 1996;223:177185.

    • Search Google Scholar
    • Export Citation
  • 117.

    Yu TK, Bhosale PR, Crane CH. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2008;71:11751180.

    • Search Google Scholar
    • Export Citation
  • 118.

    Green RJ, Metlay JP, Propert K. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 2002;136:261269.

    • Search Google Scholar
    • Export Citation
  • 119.

    Pietra N, Sarli L, Costi R. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998;41:11271133.

    • Search Google Scholar
    • Export Citation
  • 120.

    Secco GB, Fardelli R, Gianquinto D. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418423.

    • Search Google Scholar
    • Export Citation
  • 121.

    Desch CE, Benson AB, Somerfield MR. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:85128519.

    • Search Google Scholar
    • Export Citation
  • 122.

    Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007:CD002200.

    • Search Google Scholar
    • Export Citation
  • 123.

    Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813813.

    • Search Google Scholar
    • Export Citation
  • 124.

    Tepper JE, O’Connell M, Niedzwiecki D. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control—final report of intergroup 0114. J Clin Oncol 2002;20:17441750.

    • Search Google Scholar
    • Export Citation
  • 125.

    Guyot F, Faivre J, Manfredi S. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005;16:756761.

  • 126.

    Li Destri G, Di Cataldo A, Puleo S. Colorectal cancer follow-up: useful or useless? Surg Oncol 2006;15:112.

  • 127.

    Pfister DG, Benson AB 3rd, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004;350:23752382.

    • Search Google Scholar
    • Export Citation
  • 128.

    Beaugerie L, Svrcek M, Seksik P. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166175.

    • Search Google Scholar
    • Export Citation
  • 129.

    Lutgens MW, van Oijen MG, van der Heijden GJ. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19:789799.

    • Search Google Scholar
    • Export Citation
  • 130.

    Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526535.

  • 131.

    Farraye FA, Odze RD, Eaden J. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:738745.

    • Search Google Scholar
    • Export Citation
  • 132.

    Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501523; quiz 524.

    • Search Google Scholar
    • Export Citation
  • 133.

    Neumann H, Vieth M, Langner C. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011;17:31843191.

  • 134.

    Umar A, Boland CR, Terdiman JP. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261268.

    • Search Google Scholar
    • Export Citation
  • 135.

    Taylor DP, Burt RW, Williams MS. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010;138:877885.

    • Search Google Scholar
    • Export Citation
  • 136.

    Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 2012;156:703709.

    • Search Google Scholar
    • Export Citation
  • 137.

    Aaltonen LA, Salovaara R, Kristo P. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:14811487.

    • Search Google Scholar
    • Export Citation
  • 138.

    Hampel H, Frankel WL, Martin E. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:18511860.

    • Search Google Scholar
    • Export Citation
  • 139.

    Hampel H, Frankel WL, Martin E. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26:57835788.

    • Search Google Scholar
    • Export Citation
  • 140.

    Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919932.

  • 141.

    Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:20732087 e2073.

  • 142.

    Kempers MJ, Kuiper RP, Ockeloen CW. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 2011;12:4955.

    • Search Google Scholar
    • Export Citation
  • 143.

    Rumilla K, Schowalter KV, Lindor NM. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn 2011;13:9399.

    • Search Google Scholar
    • Export Citation
  • 144.

    Vasen HF, Wijnen JT, Menko FH. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:10201027.

    • Search Google Scholar
    • Export Citation
  • 145.

    Aaltonen LA, Peltomaki P, Mecklin JP. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:16451648.

    • Search Google Scholar
    • Export Citation
  • 146.

    Moslein G, Tester DJ, Lindor NM. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 1996;5:12451252.

    • Search Google Scholar
    • Export Citation
  • 147.

    Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:14051411.

    • Search Google Scholar
    • Export Citation
  • 148.

    Lindor NM, Petersen GM, Hadley DW. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:15071517.

    • Search Google Scholar
    • Export Citation
  • 149.

    Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:14531456.

    • Search Google Scholar
    • Export Citation
  • 150.

    Vasen HF. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 2000;18(21 Suppl):81S92S.

  • 151.

    Barnetson RA, Tenesa A, Farrington SM. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006;354:27512763.

    • Search Google Scholar
    • Export Citation
  • 152.

    Rodriguez-Bigas MA, Boland CR, Hamilton SR. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:17581762.

    • Search Google Scholar
    • Export Citation
  • 153.

    Raedle J, Trojan J, Brieger A. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 2001;135:566576.

    • Search Google Scholar
    • Export Citation
  • 154.

    Pinol V, Castells A, Andreu M. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005;293:19861994.

    • Search Google Scholar
    • Export Citation
  • 155.

    Ramsey SD, Clarke L, Etzioni R. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135:577588.

    • Search Google Scholar
    • Export Citation
  • 156.

    Balmana J, Stockwell DH, Steyerberg EW. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006;296:14691478.

  • 157.

    Chen S, Wang W, Lee S. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006;296:14791487.

  • 158.

    Kastrinos F, Steyerberg EW, Mercado R. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 2011;140:7381.

    • Search Google Scholar
    • Export Citation
  • 159.

    Beamer LC, Grant ML, Espenschied CR. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 2012;30:10581063.

    • Search Google Scholar
    • Export Citation
  • 160.

    Burt RW. Who should have genetic testing for the lynch syndrome? Ann Intern Med 2011;155:127128.

  • 161.

    Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:3541.

    • Search Google Scholar
    • Export Citation
  • 162.

    Ladabaum U, Wang G, Terdiman J. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 2011;155:6979.

    • Search Google Scholar
    • Export Citation
  • 163.

    Palomaki GE, McClain MR, Melillo S. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 2009;11:4265.

    • Search Google Scholar
    • Export Citation
  • 164.

    Heald B, Plesec T, Liu X. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol 2013;31:13361340.

    • Search Google Scholar
    • Export Citation
  • 165.

    Moreira L, Balaguer F, Lindor N. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308:15551565.

  • 166.

    Boland CR, Shike M. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. Gastroenterology 2010;138:2197 e2191-2197.

    • Search Google Scholar
    • Export Citation
  • 167.

    Hendriks YM, de Jong AE, Morreau H. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 2006;56:213225.

    • Search Google Scholar
    • Export Citation
  • 168.

    Caldes T, Godino J, Sanchez A. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep 2004;12:621629.

    • Search Google Scholar
    • Export Citation
  • 169.

    Vasen HF, Hendriks Y, de Jong AE. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers 2004;20:207213.

    • Search Google Scholar
    • Export Citation
  • 170.

    Hampel H, Frankel W, Panescu J. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006;66:78107817.

    • Search Google Scholar
    • Export Citation
  • 171.

    Lindor NM, Burgart LJ, Leontovich O. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:10431048.

    • Search Google Scholar
    • Export Citation
  • 172.

    Reyes CM, Allen BA, Terdiman JP, Wilson LS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 2002;95:18481856.

    • Search Google Scholar
    • Export Citation
  • 173.

    Shia J, Klimstra DS, Nafa K. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005;29:96104.

    • Search Google Scholar
    • Export Citation
  • 174.

    Pino MS, Chung DC. Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn 2010;10:651665.

  • 175.

    Lagerstedt Robinson K, Liu T, Vandrovcova J. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007;99:291299.

    • Search Google Scholar
    • Export Citation
  • 176.

    Yurgelun MB, Goel A, Hornick JL. Microsatellite instability and DNA mismatch repair protein deficiency in lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 2012;5:574582.

    • Search Google Scholar
    • Export Citation
  • 177.

    Burt RW. Diagnosing lynch syndrome: more light at the end of the tunnel. Cancer Prev Res (Phila) 2012;5:507510.

  • 178.

    Dinh TA, Rosner BI, Atwood JC. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) 2011;4:922.

    • Search Google Scholar
    • Export Citation
  • 179.

    Ward RL, Hicks S, Hawkins NJ. Population-based molecular screening for Lynch syndrome: implications for personalized medicine. J Clin Oncol 2013;31:25542562.

    • Search Google Scholar
    • Export Citation
  • 180.

    Bonadona V, Bonaiti B, Olschwang S. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011;305:23042310.

    • Search Google Scholar
    • Export Citation
  • 181.

    Engel C, Loeffler M, Steinke V. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 2012;30:44094415.

    • Search Google Scholar
    • Export Citation
  • 182.

    Kohlmann W, Gruber S. Lynch syndrome. In: Pagon RA, Adam MP, Bird TD, eds. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 19932013.

    • Search Google Scholar
    • Export Citation
  • 183.

    Kastrinos F, Mukherjee B, Tayob N. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009;302:17901795.

  • 184.

    Watson P, Vasen HF, Mecklin JP. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008;123:444449.

  • 185.

    Win AK, Young JP, Lindor NM. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 2012;30:958964.

    • Search Google Scholar
    • Export Citation
  • 186.

    Senter L, Clendenning M, Sotamaa K. The clinical phenotype of Lynch syndrome due to germline PMS2 mutations. Gastroenterology 2008;135:419428.

    • Search Google Scholar
    • Export Citation
  • 187.

    Chen LM, Yang KY, Little SE. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol 2007;110:1825.

    • Search Google Scholar
    • Export Citation
  • 188.

    Schmeler KM, Lynch HT, Chen LM. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261269.

    • Search Google Scholar
    • Export Citation
  • 189.

    Auranen A, Joutsiniemi T. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand 2011;90:437444.

    • Search Google Scholar
    • Export Citation
  • 190.

    Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009;27:47934797.

    • Search Google Scholar
    • Export Citation
  • 191.

    Renkonen-Sinisalo L, Butzow R, Leminen A. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 2007;120:821824.

    • Search Google Scholar
    • Export Citation
  • 192.

    Rijcken FE, Mourits MJ, Kleibeuker JH. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:7480.

  • 193.

    Dove-Edwin I, Boks D, Goff S. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002;94:17081712.

    • Search Google Scholar
    • Export Citation
  • 194.

    Capelle LG, Van Grieken NC, Lingsma HF. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010;138:487492.

    • Search Google Scholar
    • Export Citation
  • 195.

    Schulmann K, Engel C, Propping P, Schmiegel W. Small bowel cancer risk in Lynch syndrome. Gut 2008;57:16291630.

  • 196.

    ten Kate GL, Kleibeuker JH, Nagengast FM. Is surveillance of the small bowel indicated for Lynch syndrome families? Gut 2007;56:11981201.

  • 197.

    Koornstra JJ, Kleibeuker JH, Vasen HF. Small-bowel cancer in Lynch syndrome: is it time for surveillance? Lancet Oncol 2008;9:901905.

  • 198.

    Renkonen-Sinisalo L, Sipponen P, Aarnio M. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 2002;37:574577.

    • Search Google Scholar
    • Export Citation
  • 199.

    Vasen HF, Blanco I, Aktan-Collan K. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013;62:812823.

    • Search Google Scholar
    • Export Citation
  • 200.

    Skeldon SC, Semotiuk K, Aronson M. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol 2013;63:379385.

    • Search Google Scholar
    • Export Citation
  • 201.

    Win AK, Lindor NM, Jenkins MA. Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res 2013;15:R27.

  • 202.

    Burn J, Gerdes AM, Macrae F. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011;378:20812087.

    • Search Google Scholar
    • Export Citation
  • 203.

    Cleland JG. Does aspirin really reduce the risk of colon cancer? Lancet 2012;379:1586; author reply 1587.

  • 204.

    Jankowski J, Barr H, Moayyedi P. Does aspirin really reduce the risk of colon cancer? Lancet 2012;379:15861587; author reply 1587.

All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 978 756 34
PDF Downloads 93 67 6
EPUB Downloads 0 0 0